Estimating Lifetime or Episode-of-illness Costs
Most analysis of health care costs examine costs for fixed periods of time (e.g., annual) but are not well suited for the analysis of either lifetime costs or per episode of illness cost, such as those that occur in cost-effectiveness and some cost of illness analyses. These questions involve use of data with varying periods of observation and right censoring of cases before death or the end of the episode of illness. Although some work has been done on this issue, there are concerns about the robustness of the existing methods, especially given the extreme skewness typical of health care costs generally and these data specifically, as well as the prominence of observations with no expenditure for some short periods of observation. In this paper, we identify a major bias associated with estimators that use inverse probability weighting with the survival from censoring probabilities in estimating mean cumulative costs (Bang-Tsiatis-Lin). We propose an alternative that extends the class of two-part models to deal with random right censoring (e.g., administrative censoring), and more fully incorporates the information from the censored periods. Our model also addresses issues about the time to death in these analyses. Several simulations are conducted to highlight our proposed estimator compared to alternatives. The results support the theoretical result indicating that estimators based on inverse probability weighting yield biased estimates of accumulated costs in situations with substantial censoring. Our alternative is consistent and more efficient for these designs. We apply this approach and compare it to the alternatives from the literature using data from the Medicare-SEER files on prostate cancer using within and split sample methods. Our results indicate that the Bang-Tsiatis-Lin approach yields negative estimates of the ten year incremental costs of worse stages of prostate cancer relative to better initial grade. Our alternative indicates the opposite. The discrepancy is large in magnitude and statistically significant.
|Date of creation:||Jul 2009|
|Date of revision:|
|Contact details of provider:|| Postal: HEDG/HERC, Department of Economics and Related Studies, University of York, York, YO10 5DD, United Kingdom|
Phone: (0)1904 323776
Fax: (0)1904 323759
Web page: http://www.york.ac.uk/economics/postgrad/herc/hedg/
More information through EDIRC
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Willard G. Manning & Anirban Basu & John Mullahy, 2003.
"Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data,"
0313, Harris School of Public Policy Studies, University of Chicago.
- Manning, Willard G. & Basu, Anirban & Mullahy, John, 2005. "Generalized modeling approaches to risk adjustment of skewed outcomes data," Journal of Health Economics, Elsevier, vol. 24(3), pages 465-488, May.
- Willard G. Manning & Anirban Basu & John Mullahy, 2003. "Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data," NBER Technical Working Papers 0293, National Bureau of Economic Research, Inc.
- Anirban Basu & Willard G. Manning & John Mullahy, 2004. "Comparing alternative models: log vs Cox proportional hazard?," Health Economics, John Wiley & Sons, Ltd., vol. 13(8), pages 749-765.
- Etzioni, Ruth D. & Feuer, Eric J. & Sullivan, Sean D. & Lin, Danyu & Hu, Chengcheng & Ramsey, Scott D., 1999. "On the use of survival analysis techniques to estimate medical care costs," Journal of Health Economics, Elsevier, vol. 18(3), pages 365-380, June.
- O'Hagan, Anthony & Stevens, John W., 2004. "On estimators of medical costs with censored data," Journal of Health Economics, Elsevier, vol. 23(3), pages 615-625, May.
- Raikou, M. & McGuire, A., 2004. "Estimating medical care costs under conditions of censoring," Journal of Health Economics, Elsevier, vol. 23(3), pages 443-470, May.
- D. Y. Lin, 2000. "Proportional Means Regression for Censored Medical Costs," Biometrics, The International Biometric Society, vol. 56(3), pages 775-778, 09.
When requesting a correction, please mention this item's handle: RePEc:yor:hectdg:09/12. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Jane Rawlings)
If references are entirely missing, you can add them using this form.